137 related articles for article (PubMed ID: 9718878)
1. Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission.
Martinelli G; Zinzani PL; Magagnoli M; Vianelli N; Tura S
Haematologica; 1998 Jul; 83(7):669-70. PubMed ID: 9718878
[TBL] [Abstract][Full Text] [Related]
2. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
3. [Immune thrombocytopenia in Hodgkin's disease].
Burghuber OC; Smolen J; Kühböck J
Acta Med Austriaca; 1986; 13(2):55-9. PubMed ID: 3766088
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopaenic purpura in patients during remission of Hodgkin's disease.
Tahiliani RR; Banavali SD; Parikh PM; Charak BS; Nair CN; Saikia TK; Gopal R; Advani SH
J Assoc Physicians India; 1989 Feb; 37(2):141-3. PubMed ID: 2808278
[TBL] [Abstract][Full Text] [Related]
5. [Idiopathic thrombocytopenic purpura in Hodgkin's disease--an early sign of a recurrence (author's transl)].
Schmitt-Gräff A; Seeber S; Wetter O; Schmidt CG
Dtsch Med Wochenschr; 1978 Nov; 103(46):1839-41. PubMed ID: 568541
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic thrombocytopenic purpura in Hodgkin's lymphoma.
Patra SP; Mukherjee C
J Indian Med Assoc; 1995 Sep; 93(9):356-7. PubMed ID: 8648159
[No Abstract] [Full Text] [Related]
7. Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina.
Donato H; Picón A; Martinez M; Rapetti MC; Rosso A; Gomez S; Rossi N; Bacciedoni V; Schvartzman G; Riccheri C; Costa A; Di Santo J
Pediatr Blood Cancer; 2009 Apr; 52(4):491-6. PubMed ID: 19058214
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a report of eight cases.
Bradley SJ; Hudson GV; Linch DC
Clin Oncol (R Coll Radiol); 1993; 5(6):355-7. PubMed ID: 8305354
[TBL] [Abstract][Full Text] [Related]
9. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
Glanz J; France E; Xu S; Hayes T; Hambidge S
Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
[TBL] [Abstract][Full Text] [Related]
10. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic thrombocytopenic purpura and Hodgkin's disease: report of two cases and a review of the literature.
Kirshner JJ; Zamkoff KW; Gottlieb AJ
Am J Med Sci; 1980; 280(1):21-8. PubMed ID: 7191634
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.
Hequet O; Salles G; Ketterer N; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Bouafia F; Coiffier B
Bone Marrow Transplant; 2003 Jul; 32(1):89-95. PubMed ID: 12815483
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a rare occurrence of no prognostic significance.
Cohen JR
Cancer; 1978 Feb; 41(2):743-6. PubMed ID: 564740
[TBL] [Abstract][Full Text] [Related]
14. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
15. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
16. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
[TBL] [Abstract][Full Text] [Related]
17. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
Carella AM; Lerma E; Dejana A; Corsetti MT; Celesti L; Bruni R; Benvenuto F; Figari O; Parodi C; Carlier P; Florio G; Lercari G; Valbonesi M; Casarino L; De Stefano F; Geniram A; Venturino M; Tedeschi L; Palmieri G; Piaggio G; Podestà M; Frassoni F; Van Lint MT; Marmont AM; Bacigalupo A
Haematologica; 1998 Oct; 83(10):904-9. PubMed ID: 9830799
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease of the nasopharynx: diagnostic and therapeutic approach with a review of the literature.
Anselmo AP; Cavalieri E; Cardarelli L; Gianfelici V; Osti FM; Pescarmona E; Maurizi Enrici R
Ann Hematol; 2002 Sep; 81(9):514-6. PubMed ID: 12373352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
